Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05063929 · ClinicalTrials.gov registry record · NA
Impacts of Fruit on the Gut Health and Human Health
A NA study of Healthy Aging and Cognition, sponsored by San Diego State University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05063929: Completed NA study of Healthy Aging and Cognition, sponsored by San Diego State University.
NCT05063929 is a NA study of Healthy Aging and Cognition that has completed, run by San Diego State University. The registered enrollment target is 40 participants, below the 120-participant average among 40 other Healthy Aging trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05063929, a NA study of Healthy Aging and Cognition, has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this study are to investigate the effect of fruit consumption on the gut microbiota and their collective fecal and plasma metabolomes, vascular and cardiometabolic functions, cognition, and motor control.
Primary Outcome
Bacterial fecal microbiome 16S rRNA gene amplicon libraries will be sequence using the Illumina MiSeq next generation sequencing platform.
Conditions Studied
Interventions
- OTHER Fruit (2 cup eq)
- OTHER Fruit restriction (1/2 cup eq)
Study Locations (1)
California
- Shirin Hooshmand - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-08-15 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT05063929 record still lists
NCT05063929 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 120-participant average among 40 other Healthy Aging trials with a reported enrollment target (67% lower).
The record links to 3 conditions, with Healthy Aging appearing as the primary indexed condition, and to 2 interventions - of which Fruit (2 cup eq) is the first listed.
NCT05063929 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05063929 about?
NCT05063929 is a clinical study titled "Impacts of Fruit on the Gut Health and Human Health". The objectives of this study are to investigate the effect of fruit consumption on the gut microbiota and their collective fecal and plasma metabolomes, vascular and cardiometabolic functions, cognition, and motor control.
What is the current status of trial NCT05063929?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-08-15. Estimated completion is 2024-12-31.
What conditions does trial NCT05063929 study?
This clinical trial studies the following conditions: Healthy Aging, Cognition, Cardiometabolic Health.
What interventions are being tested in trial NCT05063929?
The interventions under investigation include: Fruit (2 cup eq) (OTHER), Fruit restriction (1/2 cup eq) (OTHER).
Who is sponsoring clinical trial NCT05063929?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05063929 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05063929's enrollment target sits among peer trials
40 32nd of 40 higher than 7 of 40 other Healthy Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study
RECRUITING · NA
-
The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots
RECRUITING · NA
-
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
RECRUITING · NA
-
Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
RECRUITING · NA
-
iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults
RECRUITING · NA
-
Reactive Balance Training for Fall Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI